| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.03 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.03 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.063 | 0.03 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.1 | 0.04 |